Aptevo Therapeutics (AP80.F) Q4 2024 Earnings

7NovConfirmed
Q4 2024
-19.53
-18.5
-17.47
-16.44

Details

Expected EPS
-19.5253329
Actual EPS
-16.4423856
Surprise EPS
3.08
Surprise Percent
+15.79%

Description

Aptevo Therapeutics (AP80.F) has reported earnings of -16.4423856 per share for Q4 2024.

0 Comments

Share your thoughts